Suppr超能文献

70 岁以下粪便免疫化学检测阴性后的结直肠癌发病率和死亡率:一项前瞻性观察研究。

Colorectal cancer incidence and mortality after negative fecal immunochemical tests by age 70: A prospective observational study.

机构信息

Veneto Tumour Registry, Azienda Zero, Padova, Italy.

Epidemiology and Screening Unit - CPO, University Hospital Città della Salute e della Scienza, Turin, Italy.

出版信息

Int J Cancer. 2021 Sep 15;149(6):1257-1265. doi: 10.1002/ijc.33682. Epub 2021 Jun 1.

Abstract

Limited endoscopy capacity usually represents the main barrier to the extension of screening to subjects older than 70, given the high positivity rate in this age group. We assessed CRC incidence and mortality by number of previous negative fecal immunochemical tests (FIT) among subjects turning 70. We selected persons aged 70 years who had received their last screening invitation when they were 68 or 69 years old within the population-based screening program in the Veneto region of Italy. Subjects with a positive FIT were excluded. We calculated 10-year cumulative CRC incidence and mortality in cohorts of subjects having performed zero, one, two or three negative FITs over the last three screening rounds before turning 70. Out of 117 858 subjects included in the study (46.4% men), 33.7% had never participated in screening (zero negative FITs), 23.3% had had one-negative FIT, 20.1% two-negative FITs and 22.9% three negative FITs. The 10-year cumulative CRC incidence was 29.7 per 1000 subjects with zero FITs, and respectively, 14.5, 11.7 and 9.6 per 1000 subjects with one, two and three negative FITs. The corresponding figures for 10-year cumulative mortality were 9.3, 3.5, 2.2 and 2.1 per 1000 in the four study cohorts. Figures were roughly double for men than for women for all the study cohorts. In order to use more efficiently limited endoscopy resources, and to minimize the potential harms related to false positive results in the elderly, screening among people aged 70 to 74 might be restricted to those with zero previous negative FITs.

摘要

由于 70 岁以上人群的阳性率较高,因此内镜检查能力有限通常是将筛查扩展到 70 岁以上人群的主要障碍。我们根据受试者在 70 岁之前进行的最后三次阴性粪便免疫化学检测(FIT)的数量评估 CRC 的发病率和死亡率。我们选择了在意大利威尼托地区基于人群的筛查计划中,当他们 68 或 69 岁时收到最后一次筛查邀请的 70 岁的人。排除了 FIT 阳性的人。我们计算了在过去三次筛查轮次之前进行了零、一、二或三次阴性 FIT 的受试者队列中,10 年 CRC 发病率和死亡率的累积发生率。在纳入研究的 117858 名受试者(46.4%为男性)中,33.7%从未参加过筛查(零次阴性 FIT),23.3%进行过一次阴性 FIT,20.1%进行过两次阴性 FIT,22.9%进行过三次阴性 FIT。零 FIT 的受试者 10 年 CRC 累积发病率为 29.7/1000 人,而一次、两次和三次阴性 FIT 的受试者分别为 14.5/1000、11.7/1000 和 9.6/1000。四个研究队列中,相应的 10 年 CRC 累积死亡率分别为 9.3/1000、3.5/1000、2.2/1000 和 2.1/1000。对于所有研究队列,男性的数字都高于女性。为了更有效地利用有限的内镜资源,并最大限度地减少老年人中假阳性结果带来的潜在危害,70 至 74 岁人群的筛查可能仅限于零次阴性 FIT 者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验